- Home
- ASST vs APRE Comparison
ASST vs APRE Comparison
Compare ASST & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASST
- APRE
- Stock Information
- Founded
- ASST 2020
- APRE 2006
- Country
- ASST United States
- APRE United States
- Employees
- ASST N/A
- APRE N/A
- Industry
- ASST Computer Software: Prepackaged Software
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASST Technology
- APRE Health Care
- Exchange
- ASST Nasdaq
- APRE Nasdaq
- Market Cap
- ASST 7.2M
- APRE 8.4M
- IPO Year
- ASST 2023
- APRE 2019
- Fundamental
- Price
- ASST $0.59
- APRE $1.62
- Analyst Decision
- ASST
- APRE Strong Buy
- Analyst Count
- ASST 0
- APRE 2
- Target Price
- ASST N/A
- APRE $15.50
- AVG Volume (30 Days)
- ASST 1.7M
- APRE 29.8K
- Earning Date
- ASST 05-14-2025
- APRE 05-13-2025
- Dividend Yield
- ASST N/A
- APRE N/A
- EPS Growth
- ASST N/A
- APRE N/A
- EPS
- ASST N/A
- APRE N/A
- Revenue
- ASST $633,489.00
- APRE $1,502,581.00
- Revenue This Year
- ASST N/A
- APRE N/A
- Revenue Next Year
- ASST N/A
- APRE N/A
- P/E Ratio
- ASST N/A
- APRE N/A
- Revenue Growth
- ASST 128.66
- APRE 157.63
- 52 Week Low
- ASST $0.34
- APRE $1.41
- 52 Week High
- ASST $3.94
- APRE $5.90
- Technical
- Relative Strength Index (RSI)
- ASST 57.18
- APRE 36.93
- Support Level
- ASST $0.50
- APRE $1.41
- Resistance Level
- ASST $0.61
- APRE $1.59
- Average True Range (ATR)
- ASST 0.07
- APRE 0.11
- MACD
- ASST 0.01
- APRE 0.03
- Stochastic Oscillator
- ASST 91.56
- APRE 48.04
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.